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Measurement of Left Ventricular Ejection Fraction in 
Pediatric Patients Using the Nuclear Stethoscope 
ROBERT L. SPICER, MD, MARK RABINOVITCH, MD, AMNON ROSENTHAL, MD, 
and BERTRAM PITT, MD 
Left ventricular (LV) ejection fraction (EF) was 
measured in 25 patients, aged 2 weeks to 20 years 
(mean 8.6 years), using a portable nonimaging 
scintillation stethoscope. Technically satisfactory 
studies were obtained in 23 patients. LVEF was 
validated by cineangiography in 19 patients and by 
standard gated blood pool scintigraphy in 4. EF 
measured by the nuclear stethoscope correlated 
well with values obtained by cineangiography or 
scintigraphy (r = 0.869, p <O.OOl) over a wide 
range of EF values ( 18 to 79 % ). In children younger 
than 5 years (n = 1 l), the correlation (r = 0.728, p 
<0.02) was less satisfactory than in those older than 
5 years (r = 0.926; p <O.OOl). Although modifica- 
tions in the instrument and further clinical trials with 
the stethoscope are needed before the device be- 
comes clinically useful to pediatric cardiologists, our 
data indicate that the nuclear stethoscope can 
provide reliable assessment of LVEF in pediatric 
patients. (Am J Cardiol 1984;53:211-214) 
Recent advances in radiopharmaceuticals, imaging 
systems and computer capabilities have allowed ap- 
plication of many nuclear cardiology techniques to pe- 
diatric patients. Radionuclide angiography has been 
applied to left and right ventricular function analysis 
in children with structurally normal hearts and those 
with congenital defects. 1-5 Since the first report on the 
use of a nonimaging scintillation probe to develop left 
ventricular (LV) time-activity curves in 1976,6 the nu- 
clear stethoscope has been shown to determine LV 
ejection fraction (EF) accurately at rest7T8 and with 
exercise” in the normals,9 and abnormal7-l1 heart. The 
present study determines the accuracy and utility of the 
nuclear stethoscope in assessing LVEF in children and 
adolescents with cardiovascular disease. 
Methods 
Patients: Twenty-five patients, aged 2 weeks to 20 years 
(mean 8.6 years), with a variety of congenital and acquired 
cardiac defects were studied with the nuclear stethoscope 
(Table I). Among the group with congenital defects, 11 had 
prior palliative or corrective surgery for the defect and 10 had 
no prior cardiac surgery. Twenty-one patients were studied 
during cardiac catheterization and LV cineangiography was 
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performed in each. In 4 patients studied on the ward or in- 
tensive care unit, a standard gated blood pool acquisition 
scintigraphy was performed. Two of 21 patients catheterized 
were excluded because of technical difficulties in achieving 
red blood cell labeling with the radiopharmaceutical. The 23 
patients with adequate stethoscope studies and either scin- 
tigraphic (n = 4) or angiographic studies (n = 19) comprise the 
study group. 
Radionuclide imaging technique: All patients underwent 
in vivo red blood cell labeling using i.v. stannous pyrophos- 
phate (10 pug Sn+“/kg) followed 15 to 20 minutes later by the 
administration of technetium-99m pertechnetate. The dose 
of technetium was calculated using a body surface nomogram 
adjusting the adult dose of 20 mCill.7 mZ to the child’s body 
surface area. The commercially available computerized nil- 
clear probe (Nuclear Stethoscope@, Bias) was used for all 
studies. The probe device, which has been described exten 
sively in previous reports,‘,Y consists of a 2-inch sodium io- 
dide crystal detector with a microcomputer which measures 
and displays a high temporal resolution (I 0 ms) image of the 
LV time-activity curve. The position/monitor mode of the 
device displays beat-to-beat time-activity curves and allows 
localization of the optimal LV and background positions with 
a series of computer-assisted algorithms. Using the positiori- 
monitor mode of the stethoscope, 10 to 20 consecutive cardiac 
cycles were identified using manually controlled cursors and 
then analyzed by the microprocessor. The microprocessor 
determination of ejection fraction was made using the formula 
(end-diastolic counts - end-systolic counts)/(end-diastolic 
counts - background counts). 
The 4 patients studied using gated blood pool techniques 
were imaged using a computerized single-crystal scintillation 
camera (Technicare Sigma 42Oa). EF was calculated hp an 
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1mr TABLE I Cardiac Diagnoses in 25 Children with Nuclear 
Stethoscope Studies 
Congenital heart defects (n = 2 1) 
Nonoperated 
Ventricular septal defect 
Pulmonary valve stenosis 
Cardiomyopathy 
Tetralogy of Fallot 
Mitral incompetence 
Endocardial cushion defect 
Postoperative 
Repaired 
Tetralogy of Fallot 
Endocardial cushion defect 
Ebstein’s anomaly s/p tricuspid 
valve replacement 
Ventricular septal defect 
Total anomalous pulmonary venous return 
Tricuspid atresia s/p Fontan 
Aortic stenosis s/p valvotomy 
Palliated 
Tricusoid atresia S/D aortooulmonarv shunt 1 
Acquired heart disease (n = 4) 
Osteosarcoma 
Myocarditis 
Complete heart block 
Kawasaki disease 
independent observer who was unaware of stethoscope results, 
using a semiautomatic edge-detection computer program on 
images obtained in the left anterior oblique projection which 
provided optimal separation of the atria and ventricles. Re- 
gional wall motion abnormalities were analyzed using 
cinematic closed-loop display. In 3 of the 4 patients studied 
by gated blood pool scintigraphy, studies were performed 
within 1 hour of the stethoscope study; in 1 patient the scin- 
tigraphic scan was performed 3 weeks after the nuclear 
stethoscope study. 
Cineangiography: LV cineangiograms were obtained using 
1 to 1.5 ml/kg body weight of diatrizoate meglumine (Renovist 
II@, Squibb) injected within 1 second. LVEF was measured 
using the area-length methodl” on digitized biplane (antero- 
posterior/lateral or anteroposterior/left anterior oblique) 
views of the heart. Measurements were made by independent 
observers not involved in the study, who had no knowledge 
of stethoscope study results. Stethoscope studies were per- 
formed 30 minutes or more after (n = 16) or immediately be- 
fore (n = 3) LV angiography. 
Comparison of the ejection fraction determined by the 
nuclear stethoscope with that determined by cineangiography 
and scintigraphy was made using standard linear regression 
analysis, correlation coefficient and paired t test. Group data 
are presented as mean f standard deviation. Statistical sig- 
nificance is at the p <0.05 level. 
Results 
LVEF measured by cineangiography in 19 patients 
ranged from 20 to 80% (mean 59 f 12) and in the 4 pa- 
tients studied by scintigraphy from 30 to 89% (mean 58 
f 21). EF determined by the nuclear stethoscope in the 
same 23 patients ranged from 18 to 79% (mean 54 f 
16%) (difference not significant). There was a direct 
relationship between LVEF determined by the nuclear 
stethoscope and cineangiography or scintigraphy (r = 
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FIGURE 1. Comparison of left ventricular injection fraction determined 
by the nuclear stethoscope and by cineangiography or gated blood pool 
scintigraphy (Muga) in 23 pediatric patients (y = 0.78x + 16.6; r = 
0.869; p <O.OOl; n = 23). 
In the 12 patients >5 years of age, whose body surface 
areas ranged from 1 to 1.83 m2 (mean 1.42), the EF 
measured by stethoscope correlated more closely to 
cineangiography or scintigraphy (Fig. 2) than in younger 
patients (Fig. 3). In children younger than 5 years (BSA 
0.23 to 0.74 m2; mean 0.43 m2) the EF measured by the 
nuclear stethoscope underestimated the values obtained 
by angiography (Fig. 3). However, the difference in 
mean EF calculated in these patients (53 f 12% vs 58 
f 7%) was not statistically significant. 
Discussion 
The present study demonstrates that the nuclear 
stethoscope can accurately estimate LVEF in the pe- 
diatric population. The stethoscope values correlate well 
with both cineangiogram and gated blood pool studies 
over a wide range of ejection fractions. The data are in 
agreement with previous studies reported in adults.7,Y 
However, EF values measured by the nuclear stetho- 
scope are not as accurate in smaller children. The ex- 
planation for this disparity may lie in the size of the 
collimator, which is designed for adults. If the field of 
view of the collimator is too large for the relatively small 
size of the pediatric heart, an overestimation of systolic 
and, to a lesser degree, diastolic counts will be made, 
resulting in underestimation of the “real” EF.7 Although 
decreasing collimator diameter could result in an ap- 
propriately limited LV field of view, the very small 
chamber volume will limit the count rate response of the 
probe.8 Patient cooperation, which might be expected 
to be less in younger patients, was not a factor in that 
it did not adversely influence the measurements in our 
study. All patients younger than 5 years of age were 
studied after being sedated for cardiac catheterization. 
Alterations in the LV field of view occurring with res- 
piratory motion7 were not observed in our patients at 
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FIGURE 2. Comparison of left ventricular ejection fraction determined FIGURE 3. Comparison of left ventricular ejection fraction determined 
by the nuclear stethoscope and by cineangiography or gated blood pool by the nuclear stethoscope and by cineangiography in 11 patients 
scintigraphy (Muga) in 12 patients older than 5 years (y = 0.92x + 8.2; younger than 5 years (y = 0.41x i- 36.6; r = 0.728; p <0.02; n = 
r = 0.926; p <O.OOl; n = 12). 11). 
rest. Although wall motion abnormalities may cause 
erroneous stethoscope values,lO none of our patients 
demonstrated wall motion abnormalities detectable by 
cineangiographic or gated blood pool studies. None of 
our patients had an abnormal spatial configuration of 
the left ventricle (dextrocardia, L-looping of ventricles), 
which may result in difficulty in identifying LV ac- 
tivity. 
In addition to potential sources of error in stethoscope 
studies, a further concern is the time involved in per- 
forming the examination. Whereas the red cell labeling 
technique is identical to that used in standard blood 
pool studies, the computer-assisted algorithms for de- 
termining optimal ventricular and background counts 
are tedious and time consuming. Small changes in probe 
position relative to the chest wall and heart can result 
in major alterations in total counts over the ventricle 
and background, altering results. Painstaking patience, 
deliberately slow movements and a nonhurried envi- 
ronment are critical for performing accurate studies. A 
good correlation has indeed been demonstrated between 
tests performed by 2 experienced operators.7 
The nuclear stethoscope has several advantages over 
other methods of LV function analysis. The first is the 
relatively low cost of the stethoscope, especially com- 
pared with any angiographic or standard gamma camera 
equipment. Second, the camera can be easily trans- 
ported to a clinic, intensive care unit or catheterization 
laboratory setting. Third, the ability of the stethoscope 
to monitor beat-to-beat function allows detection of 
rapidly changing hemodynamic events. The rapid de- 
termination and display of these events is useful in the 
evaluation of arrhythmias,ilJs and may be helpful in 
monitoring acute changes in LV function during phar- 
macologic intervention or cardiac pacing in critically ill 
or postoperative patients. Gated studies of LVEF can 
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with standard gamma camera techniques.“’ Recent 
applications of the nuclear stethoscope in adults include 
diastolic function studies,14 pressure-volume analy- 
sis15J6 and LV dysfunction in patients with coronary 
artery disease9 or adriamycin toxicity.17 The clinical 
usefulness of these applications in a pediatric popula- 
tion has not been explored. 
Our results suggest that the nuclear stethoscope can 
be used to monitor resting LVEF in pediatric patients. 
Problems with operator expertise, motion artifact and 
patient size appear to limit advances with the present 
device. Modifications in the instrument, use of different 
isotopes and further clinical investigations are required 
before this device can be considered a standard tool for 
pediatric cardiologists. 
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